Trends in inpatient antimicrobial use and appropriateness of antimicrobial therapy from 2018 to 2019: a single-center point prevalence survey.

Trends in inpatient antimicrobial use and appropriateness of antimicrobial therapy from 2018 to 2019: a single-center point prevalence survey. - A point prevalence survey for inpatient antimicrobial use.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037720

Enrollment

300

Registered

2019-08-19

Start date

2019-08-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients hospitalized at 08:00 on the survey day.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
The proportion of antimicrobial drugs that are judged to be used appropriately in all antimicrobial drugs used for treatment. We will compare this outcome with that of the 2018 point prevalence survey of our hospital.	—

Secondary

Measure	Time frame
1) The proportion of patients who receive antimicrobial drugs on the survey date. 2) The proportion of patients who have active healthcare-associated infections. 3) The proportion of cefazolin in all antimicrobial drugs that are used on the survey date.	—

Countries

Japan

Contacts

Public ContactJunpei Komagamine

National Hospital Organization Tochigi Medical Center Department of Internal Medicine

jkomagamine@tochigi-mc.jp0286225241

Outcome results